Anti-heparin antibodies: part of the repertoire of anti-endothelial cell antibodies (AECA)

Pober JS , Cotran RS . Cytokines and endothelial cell biology . Physiol Rev 1990; 70: 427–451 .

Woodroffe SB , Garnet HM , Layton JE . Cytomegalovirus infection of endothelial cells alters production of GM-CSF and G-CSF . Immunol Cell Biol 1994; 72: 187–190 .

Savage COS . Antibodies to endothelial cells . Lancet 1991; 337: 649–656 .

Penning CA , Cunningham JA , French MAH , Harrison G , Rowell NR , Hughes P . Antibody-dependent cellular cytotoxicity of human vascular endothelium in systemic sclerosis . Clin Exp Immunol 1984; 57: 548–556 .

Rosenbaum J , Pottinger BE , Woo P , et al. Measurement and characterisation of circulating anti-endothelial cell IgG in connective tissue diseases . Clin Exp Immunol 1988; 72: 450–456 .

Penning CA , French MAH , Rowell NR , Hughes P . Antibody-dependent cellular cytotoxicity of human vascular endothelium in systemic lupus erythematosus . Clin Lab Immunol 1985; 17: 125–130 .

D'Cruz DP , Houssiau FA , Ramirez G , et al. Antibodies to endothelial cells in systemic lupus erythematosus: a potential marker for nephritis and vasculitis . Clin Exp Immunol 1991; 85: 254–261 .

van der Zee JM , Miltenburg AM , Seigert CE , Daha MR , Breedveld FC . Antiendothelial cell antibodies in systemic lupus erythematosus: enhanced antibody binding to interleukin-1 stimulated endothelium . Int Arch Allergy Immunol 1994; 104: 131–136 .

Cervera R , Khamashta Ma , Font J , et al. Anti-endothelial cell antibodies in patients with anti-phospholipid syndrome . Autoimmunity 1991; 11: 1–6 .

Kaneko K, Savage COS , Pottinger BE , Shah V , Pearson JD , Dillon MJ . Anti-endothelial cell antibodies can be cytotoxic to endothelial cells without cytokine pre-stimulation and correlate with ELISA antibody measurement in Kawasaki disease . J Am Soc Nephrol 1991; 2: 598–598 .

Leung DYM, Collins T , Lapierre LA , Geha RS , Pober JS . Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon . J Clin Invest 1986; 77: 1428–1435 .

Leung DYM, Geha RS , Newburger JW , et al. Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki disease . J Exp Med 1986; 164: 1958–1972 .

Frampton G , Jayne DRW , Perry GJ , Lockwood CM , Cameron JS . Autoantibodies to endothelial cells and neutrophil cytoplasmic antigens in systemic vasculitis . Clin Exp Immunol 1990; 82: 227–232 .

Van der Zee JM , Siegert CEH , De Vreede TA , Daha MR , Breedveld FC . Characterisation of anti-endothelial cell antibodies in systemic lupus erythematosus . Clin Exp Immunol 1991; 84: 238–244 .

Chan TM , Chen IKP . A prospective study on anti-endothelial cell antibodies in patients with systemic lupus erythematosus . Clin Immunol Immunopathol 1996; 78: 41–46 .

Chan TM , Frampton G , Jayne DR , Perry GJ , Lockwood CM , Cameron JS . Clinical significance of anti-endothelial antibodies in systemic vasculitis: a longitudinal study comparing anti-endothelial cell antibodies and anti-neutrophil cytoplasmic antibodies . Am J Kidney Dis 1993; 22: 387–392 .

Leung DYM , Moake JL , Havens PL , Kim M , Pober JS . Lytic anti-endothelial cell antibodies in haemolytic-uraemic syndrome . Lancet 1988; ii: 183–183 .

Hill MB , Phipps JL , Malia RG , Greaves M , Hughes P . Characterisation and specificity of anti-endothelial cell membrane antibodies and their relationship to thrombosis in primary antiphospholipid syndrome (APS) . Clin Exp Immunol 1995; 102: 368–372 .

Pearson JD . Autoantibodies to endothelial cells. In: Catravas J , Callow AR , Ryan US , eds. Vascular Endothelium. New York: Plenum Press , 1991:117–125.

Pearson JD . Antibodies to endothelial cells and vascular dysfunction in systemic sclerosis and mixed connective tissue disease. In: Cervera P , Khamashata MA , Hughes GRV , eds. Antibodies to Endothelial Cells and Vascular Damage. Boca Raton, Fl: CRC , 1994:111–119.

Hasselaar P , Derksen R , Oostings J , Blokzijl L , de Groot P . Synergistic effects of low dose tumour necrosis factor and sera from patients with systemic lupus erythematosus on the expression of pro-coagulant activity by cultured endothelial cells . Thromb Haemostasis 1989; 62: 654–660 .

Cines DB , Tomaski A , Tannenbaum S . Immune endothelial cell injury in heparin-associatedthrombocytopenia . N Engl J Med 1987; 316: 581–589 .

Branch D , Rodgers G . Induction of endothelial cell tissue factor activity by sera from patients with antiphospholipid syndrome: a possible mechanism of thrombosis . Am J Obstet Gynaecol 1993; 168: 206–210 .

Tannenbaum SH , Finko R , Cines DB . Antibody and immune complexes induce tissue factor production by human endothelial cells . J Immunol 1986; 137: 1532–1537 .

Borrell M , Sala N , C dC Lopez S , Gari M , Foncuberta J . Immunoglobulin fractions isolated from patients with antiphospholipid antibodies prevent the inactivation of factor Va by activated protein C on human endothelial cells . Thromb Haemostasis 1992; 68: 268–272 .

Tsakiris D , Settas L , Makris P , Marbet G . Lupus anti-coagulantantiphospholipid antibodies and thrombophillia. Relation to protein Cprotein S-thrombomodulin . J Rheumatol 1990; 17: 785–789 .

Del Papa N , Guidali L , Spatola L , et al. Relationship between anti-phospholipid and anti-endothelial cell antibodies III: b2 glycoprotein I mediates the antibody binding to endothelial membranes and induces expressionofadhesionmolecules .ClinExpRheumatol 1995;13: 179–185 .

Del Papa N , Guidali L , Sironi M , et al. Anti-endothelial cell IgG antibodies from patients with Wegener's granulomatosis bind to human endothelial cells in vitro and induce adhesion molecule expression and cytokine secretion . Arthritis Rheum 1996; 39: 758–766 .

Carvalho D , Savage COS , Black CM , Pearson JD . IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro . J Clin Invest 1996; 97: 111–119 .

Del Papa N , Comforti G , Gambini D , et al. Characterisation of the endothelial cell surface proteins recognised by anti-endothelial antibodies in primary and secondary autoimmune vasculitis . Clin Immunol Immunopathol 1994; 70: 211–216 .

Koenig D , Barley Maloney L , Daniel T . A western blot assay of cryptic endothelial antigens in thrombotic microangiopathies . J Clin Immunol 1993; 87: 204–211 .

Hasselaar P , Derksen R , Blokzijl L , de Groot P . Cross-reactivity of antibodies directed against cardiolipin, DNA, endothelial cells and blood platelets . Thromb Haemostasis 1990; 63: 169–173 .

Ferraro G , Meroni PL , Tincani A , et al. Anti-endothelial cell antibodies in patients with Wegener's granulomatosis and micro-polyarteritis . Clin Exp Immunol 1990; 79: 47–53 .

Cines DB , Lyss AP , Reeber M , Bina M , DeHoratius RJ . Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus . J Clin Invest 1984; 73: 611–625 .

Shibata S , Sasaki T , Harpel P , Fillit H . Autoantibodies to heparin sulphate proteoglycan in systemic lupus erythematosus react with endothelial cells and inhibit the formation of thrombin-antithrombin III complexes . Clin Immunol Immunopathol 1994; 70: 114–123 .

Chan TM , Yu PM , Tsang KLC , Cheng IKP . Endothelial cell binding by human polyclonal anti-DNA antibodies: relationship to disease activity and endothelial functional alterations . Clin Exp Immunol 1995; 100: 506–513 .

Kramers C , Termaat R , ter Borg E , van Bruggen M , Kallenberg C . Higher anti-heparan sulphate reactivity during systemic lupus erythematosus (SLE) disease exacerbations with renal manifestations; a long-term prospective analysis . Clin Exp Immunol 1993; 93: 34–38 .

Shibata S , Harpel PC , Gharavi A , Rand J , Fillit H . Autoantibodies to heparin from patients with antiphospholipid antibody syndrome inhibit formation of antithrombin III-thrombin complexes . Blood 1994; 83: 2532–2540 .

Viscentin G , Ford S , Scott J , Aster R . Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells . J Clin Invest 1994; 93: 81–88 .

Kobayashi S , Haruta K , Takano Y , Akimoto T , Takasaki Y , Hashimoto H . Role of anti-thrombomodulin autoantibodies in scleroderma . Arthritis Rheum 1995; 38: S609–s609

Tandon N , Rock G , Jamieson G . Anti-CD36 antibodies in thrombotic thrombocytopenic purpura . Br J Haematol 1994; 88: 816–825 .

Jackson R , Brusch S , Cardin A . Glycosaminoglycans: molecular properties, protein interactions and the role in physiological processes . Physiol Rev 1991; 71: 481–539 .

Kashihara N , Makino H , Szekanecz Z , Waltenbaugh C , Kanwar Y . Nephritogenicity of anti-proteoglycan antibodies in experimental murine lupus nephritis . Lab Invest 1992; 67: 752–760 .

Miettinen A , Stow J , Mentone S , Farquhar M . Antibodies to basement membrane heparan sulphate proteoglycans bind to the laminae rarae of the glomerular basement membrane (GBM) and induce subepithelial GBM thickening . J Exp Med 1986; 163: 1064–1084 .

Fillit H , Edstrom W , Yang C-P , Moran T , Dimitriu-Bona A . Autoimmune MRL mice express high affinity IgG2b monoclonal antibodies to heparin . Clin Immunol Immunopathol 1996; 81: 62–67 .

Brinkman K , Termaat R , Berden J , Smeenk R . Anti-DNAantibodies and lupus nephritis: the complexity of cross-reactivity . Immunol Today 1990; 11: 232–234 .

Naparstek Y , Ben-Yehuda A , Madaio M , et al. Heparin neutralises nephritogenic autoantibodies in systemic lupus erythematosus . Arthritis Rheum 1991; 33: 1554–1559 .

Direskeneli H , D'Cruz D , Khamashata M , Hughes G . Autoantibodies against endothelial cells, extracellular matrix, and human collagen type IV in patients with systemic vasculitis . Clin Immunol Immunopathol 1994; 70: 206–210 .

Kincaid-Smith P , Saker B , Fairley K . Anticoagulants in ‘irreversible’ acute renal failure . Lancet 1968; 2: 1361–1363 .

Shibata S , Harpel P , Bona C , Fillit H . Monoclonal antibodies to heparin sulphate inhibit the formation of thrombin-antithrombin III complexes . Clin Immunol Immunopathol 1993; 67: 264–272 .

Abrass C , Cohen A . Characterisation of renal injury initiated by immunisation of rats with heparan sulphate . J Am Pathol 1988; 130: 103–111 .

Warkentin T , Kelton J . Heparin-induced thrombocytopenia . Prog Haemost Thromb 1991; 10: 1–34 .

Chong B . Heparin-induced thrombocytopenia . Br J Haematol 1995; 89: 431–439 .

Warkentin T , Levine M , Hirsch J , et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin . New Engl J Med 1995; 332: 1330–1335 .

Kelton J , Smith J , Warkentin T , Hayward C , Denomme G , Horsewood P . Immunoglobuln G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4 . Blood 1994; 83: 3232–3239 .

Amiral J , Bridley F , Dreyfus M , et al. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induce thrombocytopenia . Thromb Haemostasis 1992; 68: 95–96 .

Ikeda K , Nagasawa K , Hiriuchi T , Tsuru T , Nishizaka H , Niho Y . C5a induces tissue factor activity on endothelial cells . Thromb Haemost 1997; 77: 394–398 .

Suh J-S , Malik M , Aster R , Viscentin G . Characterisation of the humoral immune response in heparin-induced thrombocytopenia . Am J Haematol 1997; 54: 196–201 .

Boshkov L , Warkentin T , Hayward C , Andrew M , Kelton J . Heparin induced-thrombocytopenia and thrombosis: Clinical and laboratory studies . Br J Haematol 1993; 84: 322–322 .

Platt J , Dalmasso A , Lindman B , Ihrcke N , Bach F . The role of C5a and antibody in the release of heparan sulphate from endothelial cells . Eur J Immunol 1991; 21: 2887–2890 .

Stevens R , Wang Y , Kaji H , et al. Administration of non-anticoagulant heparin inhibits the loss of glycosaminoglycans from xenogenic cardiac grafts and prolongs graft survival . Transpl Proc 1993; 25: 382–382 .